Technology

Cardiac CT

Neurology CT

Oncology CT

Women's Health CT

Facility Management

Cardiac MRI

Neurology MRI

Oncology MRI

Women's Health MRI

Mammography

Molecular Imaging

Cardiac Ultrasound

Oncology Ultrasound

Women's Health Ultrasound

Ultrasound

Orthopedic X-Ray

X-Ray

News

All News

Blogs

Media

Around the Practice 

Between the Lines

Image IQ

Medical World News

Podcasts

Rad-View

Videos

Conferences

Conference Coverage

Conference Listing

DI Executive

Resources

CME/CE

E-books

Education

Interactive Tool Kits

Partners

Subscribe

Diagnostic Imaging serves as the connection to Radiology, including groundbreaking Imaging news and interviews with top Radiologists in multimedia formats.

Advertise

About

Contact Us

Editorial

Editorial Board

Do Not Sell My Personal Information 

Privacy

Terms and Conditions

Diagnostic Imaging - Radiology News, Imaging Expert Insights

Facebook

LinkedIn

YouTube

Spotlight

RSNA

Disease Spotlight: Prostate Cancer

Rad-View: Generic Contrast Agents 

Rad View: PSMA PET Imaging Recommendations

Unlock AI-Powered Imaging

Image IQ Quiz

Topics

View More

1rem

Topic

Previously cleared for liver tumor ablation therapy, the BioTraceIO360 ultrasound software reportedly bolsters pre-procedure planning with ablation zones.

FDA Expands Clearance of Ultrasound-Based Software for Percutaneous Soft Tissue Ablation in the Kidney

For masses interpreted as BI-RADS category 4 and 5 presentations on breast ultrasound, the authors of a new study found that the presence of echogenic rind had an 81 to 85 percent specificity for malignancy.

Echogenic Rind on Breast Ultrasound Associated with High Specificity for Malignancy

Findings from a multivariable analysis revealed that increased pulse wave velocity-end of systole (PWV-ES), assessed with ultrafast ultrasound, was associated with more than double the cardiovascular risk in young individuals with no major cardiovascular risk factors.

Ultrafast Ultrasound Study Shows Link Between Carotid Stiffening and Cardiovascular Risks in Younger Populations

The Voluson Performance 18 and 16 ultrasound devices reportedly combine enhanced imaging capabilities with AI-enabled efficiencies.



GE HealthCare Launches AI-Powered Voluson Performance 18 and 16 Ultrasound Systems

The AI-powered cardiovascular ultrasound device reportedly offers enhanced spatial and contrast resolution as well as bolstered 4D imaging that enables improved evaluation of cardiac function for a wide range of patients.

GE HealthCare Launches Vivid Pioneer Ultrasound Platform at ESC Conference

For patients with undifferentiated dyspnea, cardiopulmonary point-of-care ultrasound (POCUS) may have a considerable impact in reducing length of stay and hospitalization costs, according to recent research.

Assessing the implementation of cardiopulmonary POCUS (Butterfly iQ3) in a cohort of 208 patients (median age of 71) with undifferentiated dyspnea, the authors of a new study published in 

 found over a three-day reduction in expected length of stay (LOS) in comparison to a control group (8.3 mean LOS days vs.11.9 mean LOS days).

, Partho Sengupta, M.D., said cardiopulmonary POCUS helped rule out significant cardiovascular causes of dyspnea in a “high number of instances,” obviating the need for additional tests and longer hospital stays. Cardiopulmonary POCUS also enabled hospitalists to detect a wide variety of conditions, ranging from left ventricular dysfunction to pulmonary edema, and facilitate changes in treatment plans, according to Dr. Sengupta.

“(In) 30 percent of cases, (cardiopulmonary POCUS) contributed to a major change in how the patients were managed,” pointed out Dr. Sengupta, a Henry Rutgers Professor of Cardiology and chief of the Division of Cardiovascular Diseases and Hypertension at Robert Wood Johnson Medical School in New Brunswick, N.J.

Cumulative analysis from the study revealed that cardiopulmonary POCUS was associated with a 246 hospital bed day reduction as well as $751,573 in cost savings.

“ … That was a cumulative impact on the length of the stay and also on the hospital cost, which is huge. Imagine if you multiply that, there's so many patients. … (Usually, there is) increased cost when you introduce a new technology. (This is) one of the rare ones where you reduce the cost and length of stay, which is very exciting,” added Dr. Sengupta.

(Editor’s note: For related content, see “

POCUS Improves Diagnostic Certainty for Dyspnea Patients, ACP Says

Portable Imaging and Radiology: Where Things Stand with Point-of-Care Diagnostics

Fujifilm Sonosite Unveils High-Frequency Transducer for Point-of-Care Ultrasound

For more insights from Dr. Sengupta and Davinder Ramsingh, Ph.D., the vice president of clinical research and development for Butterfly Network, watch the video below.

In a recent interview, Partho Sengupta, M.D., and Davinder Ramsingh, Ph.D., discussed recent research demonstrating the capability of point-of-care ultrasound (POCUS) to facilitate reduced length of stay and significant cost savings in the management of patients with dyspnea.

Can Cardiopulmonary POCUS Enhance Detection and Management of Undifferentiated Dyspnea?

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

In light of emerging research suggesting an 

increased incidence of breast cancer among women under the age of 40

, Drs. Jean Seely, MD, Zeeshan Shah, MD and Amy Patel, MD, discussed what they’re seeing in practice and emphasized increased vigilance to facilitate early detection.

In a new retrospective study published earlier this week in the 

the impact of radiation exposure from medical imaging

 in a cohort of over 3.7 million children. They estimated that radiation exposure from imaging may be associated with 10.1 percent of hematologic cancers in this patient population.

, Drs. Noa Antonissen and Colin Jacobs discussed new research suggesting that a CT-based deep learning model may facilitate 

a nearly 40 percent reduction in false positives with indeterminate lung nodules

Multiple nuclear medicine societies, including the Society of Nuclear Medicine and Molecular Imaging, unveiled 

guidelines this week for PET myocardial perfusion imaging (MPI)

. Check out our takeaways from the new recommendations on appropriate protocols and keys for interpretation of PET MPI.

In a new breast ultrasound study focusing on BI-RADS category 4 and 5 mass presentations, researchers noted that the 

 had an 81 to 85 percent specificity for malignancy.

Diagnostic Imaging's Weekly Scan is your chance to catch up on the latest radiology content, from new research and device news to the latest conference reports.

Diagnostic Imaging's Weekly Scan: September 14 — September 20

Catch up on the top radiology content of the past week.

While Marfan syndrome is a clinical diagnosis, Alan C. Braverman, M.D., FACC, noted in a recent interview that radiologists play an “invaluable” role in facilitating early diagnosis of this genetic aortic condition.

“They can be the first to put the words into a clinician's mind that this condition that they're seeing on imaging could be something much more,” emphasized Dr. Braverman, the director of the Marfan Syndrome and Aortopathy Center at the Washington University School of Medicine in St. Louis, Mo.

“When there are combinations of findings — root aneurysm, tortuous arteries, mitral valve prolapse — when these features are seen on an imaging study, not just reporting them in diameters accurately, but also suggesting the possibility of something more, like Marfan syndrome or some genetic aortic condition when unexplained in a young person, in particular, can be so helpful to the clinician. It's invaluable.”

For patients with Marfan syndrome, Dr. Braverman emphasized complete assessment of the proximal aorta. Noting that an enlarged aortic root is common in this patient population, Dr. Braverman said the diameter of the aortic root generally exceeds 40 millimeters in younger male patients and 37 millimeters in younger female patients.

While these findings can be visualized very well on echocardiogram, cross-sectional imaging with computed tomography angiography (CTA) or magnetic resonance angiography (MRA) are recommended for initial diagnosis in adult patients and can aid in differentiating between Marfan syndrome and other conditions, such as Loeys-Dietz syndrome, noted Dr. Braverman, a professor of medicine and alumni endowed professor of cardiovascular diseases at the University of Washington School of Medicine.

Improving Adherence to Best Practices for Incidental Abdominal Aortic Aneurysms on CT and MRI

Emerging ECG-Based AI Screening Software for Aortic Valve Stenosis Gets FDA’s Breakthrough Device Designation

Cardiac Ultrasound Update: FDA Clears Software with 45 Automated Parameters for Echocardiographic Analysis

For more insights from Dr. Braverman, watch the video below.

Alan Braverman, MD, discusses the role of radiologists in facilitating the timely diagnosis of Marfan syndrome.

Pertinent Insights into the Imaging of Patients with Marfan Syndrome

Emphasizing the role of radiologists in facilitating timely diagnosis of Marfan syndrome, Alan Braverman, M.D. discussed the use of echocardiography, CT, and MRI in evaluating patients with this genetic aortic condition.

While the final rule for the Mammography Quality Standards Act (MQSA) with respect to a national standard for breast density notification on mammography reports was issued in March 2023, implementation has been a significant undertaking.

“For states that did not have a breast density law before, I think this is a very heavy lift,” noted Stamatia Destounis, M.D., FACR, FSBI, FAIUM, a breast imaging specialist with Elizabeth Wende Breast Care in Rochester, N.Y., and chair of the American College of Radiology (ACR) Breast Imaging Commission.

Noting that breast density notification has been the law since January 2013 in New York, Dr. Destounis emphasized the importance of ongoing education for staff, patients and referring physicians. She recalled it taking about three to four years before physicians started asking questions about breast density.

In anticipation of the nationwide standard for breast density notification going into effect on September 10, 2024, Dr. Destounis said her facility revamped their website and emphasized social media to spread the word to patients. Accordingly, she has seen an “uptick of calls and appointments” for patients seeking genetic counseling at her facility, which has led to increased supplemental breast MRI screening.

“Many go ahead and schedule their supplemental screening with their mammogram,” added Dr. Destounis.

In order to accommodate the increased imaging volume. Dr. Destounis said her facility has hired more staff, expanded hours during the week and added weekend hours as well.

While the ongoing educational, logistical, and staffing challenges can be onerous, Dr. Destounis emphasized that every week, she is seeing cases of small invasive breast cancers on ultrasound and linear ductal enhancement on breast MRI that cannot be found on standard mammography.

Current Insights on National Breast Density Notification for Mammography Reports

Looking at Next Steps to Reinforce National Breast Density Notification

Long-Term Study Shows Merits of Contrast-Enhanced Mammography for Women with Higher Breast Cancer Risk

For more insights from Dr. Destounis, watch the video below.

In a recent interview, Stamatia Destounis, MD, discussed the impact of national breast density notification for mammography reports.

Addressing the Early Impact of National Breast Density Notification for Mammography Reports

In a recent interview, Stamatia Destounis, M.D., discussed the impact of national breast density notification for mammography reports and key considerations with staffing and ongoing education for patients, staff and referring providers on the merits of supplemental breast imaging.

Stacy Smith-Foley, M.D., was pleased to see the United States Preventive Services Task Force (USPSTF) realign with the American College of Radiology (ACR) and the Society of Breast Imaging (SBI) in recommending mammography screening to begin at 40 years of age for women of average risk for breast cancer.

However, in a recent interview, Dr. Smith-Foley expressed disappointment with the 

USPSTF’s lack of support for supplemental imaging in women with dense breasts and continued mammography screening for women 75 and older

, as well as the emphasis on biennial mammography screening for women 40 to 74 years of age.

Yearly mammography screening gives women the best chance for early breast cancer detection, emphasized Dr. Smith-Foley, the medical director of the Breast Center at the Central Arkansas Radiation Therapy Institute (CARTI) in Little Rock, Arkansas.

“When women skip their mammogram intentionally or unintentionally, … we tend to find more advanced disease. The breast cancer is larger, it is more extensive, it is more often a higher grade and more frequently involves the axilla with local regional metastasis. What I see in clinical practice is that when we have these gaps or delays (with mammography screening), the disease is more extensive,” explained Dr. Smith-Foley.

Biennial Mammography Over Annual Mammography? USPSTF Issues Updated Breast Cancer Screening Recommendations

Mammography Study Shows Link Between Enlarged Axillary Lymph Nodes and Higher Risks for Diabetes and Cardiovascular Disease

Breast MRI and Dense Breasts: A Closer Look at Early Findings from a New Prospective Trial

Dr. Smith-Foley also disagrees with the USPSTF’s assertion of insufficient evidence to continue annual mammography screening in women 75 and older.

“I have a whole collection of patients under my care in their 80s and 90s who presented to me with locally advanced breast cancer that would have been detected at an earlier stage if they had been participating in yearly screens,” maintained Dr. Smith-Foley.

For more insights from Dr. Smith-Foley, watch the video below.

Stacy Smith-Foley, MD discusses shortcomings with the recently updated USPSTF breast cancer screening recommendations.

Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD

In a recent interview, Stacy Smith-Foley, M.D., shared her perspective on the shortcomings of the recently issued breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).

Eric Secemsky, M.D. says there can be a fair amount of assumptions and guesswork with sole reliance on angiography to inform peripheral vascular interventions.

For example, an angiogram provides “a very poor understanding” of a significant amount of pathology that occurs on the luminal surface of the vessel, noted Dr. Secemsky in a recent interview. He maintained that intravascular ultrasound can provide greater clarity on this pathology as well as lesion severity and morphology, vessel measurements and where disease segments begin and end.

“These are just a few of the many areas where intravascular imaging catheters can really help augment and support angiography,” noted Dr. Secemsky, the director of vascular intervention and section head of interventional cardiology and vascular research with the Smith Center for Outcomes Research in Cardiology at the Beth Israel Deaconess Medical Center in Boston.

To that end, Dr. Secemsky recently led a multidisciplinary roundtable discussion, comprised of interventional radiologists, interventional cardiologists, and vascular surgeons, to discuss 

emerging evidence on the use of intravascular ultrasound

 to bolster decision-making and help improve outcomes for peripheral vascular interventions in the lower extremity.

Key Takeaways from Multidisciplinary Roundtable on Intravascular Ultrasound Use for Peripheral Vascular Interventions

Intravascular Ultrasound for Lower Extremity Interventions: Seven Takeaways from New Global Consensus Recommendations

While acknowledging different practice settings and pressures to turn over rooms for procedures, Dr. Secemsky said the perception that using imaging catheters increases procedure time is a fallacy. Research in the coronary intervention space has demonstrated that increased familiarity with imaging catheters shows no increased procedure time and additional benefits such as reduced radiation time and exposure to contrast media, according to Dr. Secemsky, an assistant professor of medicine at Harvard Medical School.

For further insights from Dr. Secemsky, watch the video below.

Eric Secemsky, M.D., discusses advantages of intravascular ultrasound (IVUS) in supplementing angiography for peripheral vascular interventions.

Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions

In a recent interview, Eric Secemsky, M.D., discussed an array of benefits for the use of intravascular ultrasound (IVUS) in supplementing angiography for peripheral vascular interventions, current barriers preventing more widespread adoption of the technology and other salient insights from a recent multidisciplinary roundtable discussion.

Reportedly 365,000 people in the United States had breast augmentation procedures in 2021.

 Emerging research comparing digital breast tomosynthesis (DBT) use in women with and without breast implants found a 22 percent lower cancer detection rate for women with breast implants. Yet there are currently no imaging guidelines specifically geared to breast cancer screening in patients with breast implants.

Society of Breast Imaging (SBI) conference

, Stephen Rose, M.D, pointed out the breast implants may obscure between nine to 44 percent of glandular tissue on imaging. In a recent video interview, Dr. Rose said there are a number of factors, ranging from age of the implant and fibrosis to implant size, implant-related scarring and breast size, that can affect interpretation of breast imaging in patients with breast implants.

In retrospective research presented at the SBI conference, Dr. Rose and colleagues reviewed data from 350,845 DBT exams (including 20,929 DBT exams for women with breast implants) performed at 49 community-based outpatient imaging centers in 2019. In addition to the aforementioned lower cancer detection rate in women with implants, Dr. Rose and colleagues found that women with breast implants had a nearly 5.5 percent increase in ductal carcinoma in situ (DCIS) and a 4.8 percent higher incidence of positive lymph node involvement in detected cancers.

Breast Reconstruction: Current Principles and Emerging Concepts in Imaging

Study Highlights Use of Contrast-Enhanced Mammography in Women with Breast Implants

Has the time come for imaging guidelines that are more specific to the nuances and supplemental imaging needs for women with breast implants?

“Other than the same guidelines we use for women without breast implants, there really hasn’t been any specific guidelines by our societies that suggest doing more (for women with breast implants),” noted Dr. Rose, the founder and president of Rose Imaging Specialists. “It’s all been pretty anecdotal recommendations and it’s not like this is an insignificant number of patients. In some of our populations, 10 to 15 percent have implants.”

For more insights from Dr. Rose, watch the video below.

1. The Aesthetic Society. Aesthetic Plastic Surgery National Databank Statistics 2020-2021. Available at: https://cdn.theaestheticsociety.org/media/statistics/2021-TheAestheticSocietyStatistics.pdf . Accessed June 14, 2023.

In a recent video interview, Stephen Rose, M.D., reviewed a variety of factors that can impact interpretation of breast imaging for women with breast implants and discussed recent research showing a 22 percent reduction in cancer detection rate for this population in comparison to women without breast implants.

Radiology Challenges with Breast Cancer Screening in Women with Breast Implants

When evaluating an artificial intelligence (AI) model for initial assessment of left ventricular ejection fraction (LVEF) on echocardiograms, David Ouyang, M.D., said he was genuinely surprised that cardiologists had greater confidence in initial AI assessments than those provided by cardiac sonographers with an average of 14.1 years of experience.

In the randomized trial, recently published in 

, cardiologists revised 27.2 percent of initial LVEF assessments by sonographers in comparison to 16.8 percent of AI assessments.

“We initially thought of the tool as kind of a streamlining tool where it speeds things up. We actually designed the trial as a non-inferior trial. We weren’t expecting AI to be better than sonographers. Hopefully, it would be equivalent,” noted Dr. Ouyang, who is affiliated with the Department of Cardiology at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at the Cedars-Sinai Medical Center in Los Angeles. “We were pleasantly surprised that AI actually was superior. This really speaks to the high level of precision that automation delivers.”

Study Finds AI More Effective Than Sonographer Interpretation of Cardiac Function on Echocardiograms

Can AI Improve Triage of CT Pulmonary Angiography Exams for Acute PE?

AI Platform for Ultrasound Detection of Cardiac Amyloidosis Gets FDA Breakthrough Device Designation

In a recent interview, Dr. Ouyang also discussed another 

 that employed deep learning segmentation of cardiac magnetic resonance imaging (MRI) to examine how variations in left ventricle sphericity can impact cardiovascular risks. Based on their findings from a large cohort of nearly 39,000 participants from the UK Biobank, Dr. Ouyang and colleagues found that one standard deviation increase in the left ventricle sphericity index led to a 47 percent increased risk for cardiomyopathy and a 20 percent higher risk of atrial fibrillation.

For more insights from Dr, Ouyang, watch the video below.

In a recent video interview, David Ouyang, M.D., shared insights from two recent studies he co-authored on the use of artificial intelligence (AI) to improve initial assessment of left ventricular ejection fraction (LVEF) on echocardiography and ascertain cardiac risks associated with changes in the left ventricle sphericity index seen on magnetic resonance imaging (MRI).

Emerging AI Advances in Cardiac Imaging

Recently published research suggests an emerging handheld ultrasound technique could be beneficial for breast cancer screening in underserved populations with limited or no access to conventional imaging modalities.

, assessed volume sweep imaging (VSI) of 170 palpable breast lumps with a handheld ultrasound probe (Butterfly iQ, Butterfly Network). The handheld VSI ultrasound scans were performed by medical students who received less than two hours of training on the VSI protocol and had no prior ultrasound training, according to the study.

The researchers found that the VSI handheld ultrasound technique had a 97 percent sensitivity for breast masses and an 87 percent agreement with conventional ultrasound devices on Breast Imaging-Reporting and Data System (BI-RADS) assessments.

In a recent video interview, Thomas Marini, MD, discussed the VSI technique, the study findings, and the global need for increased access to ultrasound imaging.

“The Pan-American Health Organization (PAHO) estimates that two-thirds of people in the world don’t have access to any form of medical imaging and that 70 to 80 percent of their conditions can be diagnosed with basic modalities like ultrasound and X-ray,” noted Dr. Marini, who is affiliated with the University of Rochester Medical Center.

For more insights from Dr. Marini, watch the video below.

In a recent video interview, Thomas Marini, MD discussed the need for ultrasound access to facilitate breast cancer screening in underserved populations and the potential utility of volume sweep imaging, a handheld ultrasound technique that requires minimal training and has a high rate of agreement with conventional ultrasound on BI-RADS assessments.

Can Volume Sweep Imaging with Ultrasound be a Viable Option for Breast Cancer Screening in Underserved Countries?

The purchase of new and cutting-edge imaging equipment comes with a lot of excitement—and a learning curve. That's where Canon Medical Education comes in, providing a host of education solutions for clients that include both in-person and virtual training and continuing education opportunities.

The education arm of Canon Medical Systems USA provides a customizable plan to ensure that all imaging associates are well-trained and comfortable operating advanced equipment including MR and CT, as well as vascular and cath applications, among others. 

Understanding that every learner is different, Canon offers educational opportunities that include in-person, at their Institute of Advanced Imaging in Irvine, California; on-site training at a client facility; online and instructor-led courses in their Canon Learning Center; as well as CE and non-CE webinars and special programs.

To learn more about Canon's educational offerings, 

Canon Medical Systems offer a range of in-person and virtual educational opportunities for their clients. 

Women's Health Ultrasound

Latest News